16.12.2015 09:00:18
|
NNIT A/S: Kinapse and NNIT enter into partnership
Press release
Together, Kinapse and NNIT will deliver world class regulatory, pharmacovigilance and clinical business process outsourcing services.
Copenhagen, December 16, 2015 - NNIT, a leading provider of IT services and consultancy today announced that Kinapse and NNIT have entered into a worldwide partnership with a joint go-to-market offering targeted at the global R&D life science customer-segment.
Kinapse, a global provider of expert clinical, regulatory and pharmacovigilance advisory and operational services to the world's leading life sciences companies will deliver advisory services and business process outsourcing (BPO) services. NNIT will act as IT service provider and deliver wall-to-wall IT services, including infrastructure, architecture, design, development, implementation, application maintenance, support and hosting.
Together, Kinapse and NNIT will provide a complete BPO service incorporating a fast and secure platform.
"We are very happy about the partnership with Kinapse," says Rasmus Nelund, Vice President for Life Sciences at NNIT. "The partnership will allow us to supply an all-inclusive solution for outsourced services that enables secure, fast and reliable IT services. Our customers will benefit from our combined expertise and experience peace of mind when placing their business process operations with us."
"The combined offering of world class Regulatory, PV and Clinical services from Kinapse and NNIT is transformational and I think will be of significant interest to our clients who are looking for reliable partners who are dedicated to our industry and offer a fully integrated service," says Jonathan Peachey, Board Director and Head of Client Partnerships at Kinapse.
Marc Gabriel, Global Head of Regulatory Operations and Information Management Advisory services at Kinapse, notes: "Our clients have been sourcing R&D BPO services in the marketplace for many decades. They are now looking to take the next step and bundle BPO and technology to a trusted team in a single unit-based transactions. NNIT is the ideal partner for this type of joint offering."
More information
Rikke Dalager, NNIT Communications, +45 30 77 80 80, rida@nnit.com
About Kinapse
Kinapse provides expert consulting and outsourcing services to life sciences organisations. Their clients include many of the world's leading pharmaceutical companies, their customers, suppliers and regulators. Kinapse uses a novel operating and delivery model that allows them to bring together the very best people in virtual teams, in a wide range of R&D domains, committed to the success of our clients. Headquartered in London, Kinapse currently employs over 500 people in the U.K., U.S. and India. For more information, please visit www.kinapse.com
About NNIT
NNIT is an international consultancy in the development, implementation, validation and operation of IT for the life sciences industry. We create value for our clients by treating their IT as if it was our own, and of course, we meet the industry's strictest regulatory requirements. We apply the latest advances in technology to make our clients' software, business processes and communication more effective. As of July 2015, NNIT A/S had more than 2,500 employees. For more information please visit www.nnit.com.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: NNIT A/S via Globenewswire
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu NNIT A-Smehr Nachrichten
22.10.24 |
NNIT A/S: NNIT adjusts 2024 financial outlook (GlobeNewswire) |
Analysen zu NNIT A-Smehr Analysen
Aktien in diesem Artikel
NNIT A-S | 12,38 | -2,06% |